title: Inhibition of HIV-1 infectivity with curdlan sulfate in vitro.
authors.affiliation: Ajinomoto Co., Inc., Tokyo, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Kaneko
authors.forename: O
authors.initials: O
authors.lastname: Yoshida
authors.forename: R
authors.initials: R
authors.lastname: Nakagawa
authors.forename: T
authors.initials: T
authors.lastname: Yoshida
authors.forename: M
authors.initials: M
authors.lastname: Date
authors.forename: S
authors.initials: S
authors.lastname: Ogihara
authors.forename: S
authors.initials: S
authors.lastname: Shioya
authors.forename: Y
authors.initials: Y
authors.lastname: Matsuzawa
authors.forename: N
authors.initials: N
authors.lastname: Nagashima
authors.forename: Y
authors.initials: Y
authors.lastname: Irie
mesh_terms: D000818:Animals; D000998:Antiviral Agents; D015496:CD4-Positive T-Lymphocytes / Q000382:microbiology; D002460:Cell Line; D005936:Glucans / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D006168:Guinea Pigs; D015497:HIV-1 / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D007928:Lethal Dose 50; D051379:Mice; D051381:Rats; D011919:Rats, Inbred Strains; D047071:beta-Glucans
chemical_list: D000998:Antiviral Agents; D005936:Glucans; D047071:beta-Glucans; C063130:curdlan sulfate